JENKINS_HEALTH_CARE_LIMIT - Accounts


Company Registration No. 06873327 (England and Wales)
JENKINS HEALTH CARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
JENKINS HEALTH CARE LIMITED
COMPANY INFORMATION
Directors
Mr B J Jenkins
Mrs M E Jenkins
Mr T S Jenkins
Company number
06873327
Registered office
Hollins Care Centre
The Hollins
Cimla
NEATH
UK
SA11 3BQ
Auditor
MHA Broomfield Alexander
Charter Court
Phoenix Way
Enterprise Park
SWANSEA
UK
SA7 9FS
JENKINS HEALTH CARE LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Group balance sheet
9
Company balance sheet
10
Group statement of changes in equity
11
Company statement of changes in equity
12
Group statement of cash flows
13
Notes to the financial statements
14 - 26
JENKINS HEALTH CARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2018
- 1 -

The directors present the strategic report for the year ended 31 March 2018.

Fair review of the business

The Group has homes based in Neath and Swansea. The Group specialises in providing high quality, mental and social to its residents in a safe and comfortable environment.

 

The most recent Care Inspectorate Wales ("CIW") reviews were carried out in July and October 2018 for the Group's care homes, the reports were wholly positive and are available to the public via the CIW website. The reports communicate there were no areas of non-compliance during the current or previous period.

 

Despite average occupancy rates remaining consistent through the year, an increase in amounts receivable from local authorities per resident has resulted in revenues decreasing from £3,492,016 to £3,364,508. This decrease in turnover as well as increased running costs has resulted in a decrease in operating profits during the year from £193,452 to a loss of £18,626. Such increased running costs is a necessity to ensure the best possible care and living environment can be provided to the residents.

Key Performance Indicators
2018
2017
Occupany rate
85.2%
83.3%
Turnover
£3,364,508
£3,492,016
Operating (loss)/profit
(£18,626)
£193,452
Environmental matters

The Group recognises the importance of its environmental responsibilities and accepts that concern for the environment and it's employees and residents is an integral and fundamental part of its strategy. The Group monitors its impact on the environment and endeavours to design and implement policies and processes to reduce any damage that might be caused by the company's activities. Initiatives include the safe disposal of clinical waste, the minimisation of waste going to landfill, reducing energy consumption and the use of renewable resources where possible.

 

Employee involvement

The Group involves its employees in its objectives, plans and performance and on other relevant matters of interest to employees through various communications methods and regular management meetings. The Group is an equal community employer and does not discriminate in the recruitment and promotion of staff.

Future developments

The Group will continue to focus on sustained occupancy rates and improving profitability whilst also endeavouring to deliver high quality care and standards of service to all its residents.

Principal risks and uncertainties

The principal trading risks continue to be the budgetary constraints on local authorities and their continuing policy of providing care at home wherever possible resulting in reduced referrals for residential and nursing homes.

JENKINS HEALTH CARE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 2 -
Financial risk management objectives and policies

The Group operates a number of risk management policies designed to minimise its exposure to financial risk.

 

Liquidity and cash flow risk                

The Group produces detailed management accounts and forecasts, which enable the directors to monitor the cash position and to ensure that ther is sufficient liquidity and cash flow to minimise the risk of the Group being able to pay its debts as they fall due.    

                    

Interest rate risk                

The Group utilises a number of financial instruments including bank loans and overdrafts in order to finance its operations. The primary risk faced by the Group as a result of its use of these financial instruments is interest rate risk.                

 

The bank overdraft borrowings at variable rates expose the Group to cash-flow interest risk, however the directors actively manage this risk by maintaining sufficient cash reserves within the Group to avoid using its overdraft facilities wherever possible.                

                

On behalf of the board

Mr B J Jenkins
Director
17 December 2018
JENKINS HEALTH CARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2018
- 3 -

The directors present their annual report and financial statements for the year ended 31 March 2018.

Principal activities

The principal activity of the group was residential activities for the elderly and disabled.

 

100 Ordinary £1 shares were issued during the year as part of a share for share exchange whereby the Group acquired 100% of the issued share capital of Cherish Care Homes (Wales) Limited, a company which was under common ultimate control.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr B J Jenkins
Mrs M E Jenkins
Mr T S Jenkins
Results and dividends

The results for the year are set out on page 8.

No ordinary dividends were paid during the current or previous year.

Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

JENKINS HEALTH CARE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 4 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

On behalf of the board
Mr B J Jenkins
Director
17 December 2018
JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 5 -
Opinion

We have audited the financial statements of Jenkins Health Care Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2018 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2018 and of the group's loss for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

  • the directors' use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or

  • the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the group's or the parent company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 6 -

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  • adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

  • the parent company financial statements are not in agreement with the accounting records and returns; or

  • certain disclosures of directors' remuneration specified by law are not made; or

  • we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the group's and the parent company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: http://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

JENKINS HEALTH CARE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF JENKINS HEALTH CARE LIMITED
- 7 -

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Matthew Thomas (Senior Statutory Auditor)
for and on behalf of MHA Broomfield Alexander
17 December 2018
Chartered Accountants
Statutory Auditor
Charter Court
Phoenix Way
Enterprise Park
SWANSEA
UK
SA7 9FS
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2018
- 8 -
2018
2017
Notes
£
£
Turnover
3
3,364,508
3,492,016
Cost of sales
(258,437)
(186,643)
Gross profit
3,106,071
3,305,373
Administrative expenses
(3,124,697)
(3,151,921)
Other operating income
-
40,000
Operating (loss)/profit
4
(18,626)
193,452
Interest receivable and similar income
7
4,937
6,108
Interest payable and similar expenses
8
(79,348)
(80,338)
(Loss)/profit before taxation
(93,037)
119,222
Tax on (loss)/profit
9
(43,951)
(72,637)
(Loss)/profit for the financial year
(136,988)
46,585
(Loss)/profit for the financial year is all attributable to the owners of the parent company.
Total comprehensive income for the year is all attributable to the owners of the parent company,
JENKINS HEALTH CARE LIMITED
GROUP BALANCE SHEET
AS AT
31 MARCH 2018
31 March 2018
- 9 -
2018
2017
Notes
£
£
£
£
Fixed assets
Goodwill
10
188,410
314,017
Tangible assets
11
4,485,145
4,591,547
4,673,555
4,905,564
Current assets
Stocks
15
8,500
9,777
Debtors
16
448,485
447,048
Cash at bank and in hand
79,144
143,461
536,129
600,286
Creditors: amounts falling due within one year
17
(738,303)
(728,637)
Net current liabilities
(202,174)
(128,351)
Total assets less current liabilities
4,471,381
4,777,213
Creditors: amounts falling due after more than one year
18
(2,285,963)
(2,454,907)
Provisions for liabilities
20
(338,500)
(338,500)
Net assets
1,846,918
1,983,806
Capital and reserves
Called up share capital
21
200
100
Revaluation reserve
1,452,987
1,486,074
Profit and loss reserves
393,731
497,632
Total equity
1,846,918
1,983,806
The financial statements were approved by the board of directors and authorised for issue on 17 December 2018 and are signed on its behalf by:
17 December 2018
Mr B J Jenkins
Director
JENKINS HEALTH CARE LIMITED
COMPANY BALANCE SHEET
AS AT 31 MARCH 2018
31 March 2018
- 10 -
2018
2017
Notes
£
£
£
£
Fixed assets
Investments
12
1,788,854
1,788,754
Current assets
Debtors
16
55,869
33,000
Cash at bank and in hand
11,331
17,163
67,200
50,163
Creditors: amounts falling due within one year
17
(585,808)
(567,648)
Net current liabilities
(518,608)
(517,485)
Total assets less current liabilities
1,270,246
1,271,269
Creditors: amounts falling due after more than one year
18
(973,084)
(1,020,749)
Net assets
297,162
250,520
Capital and reserves
Called up share capital
21
200
100
Profit and loss reserves
296,962
250,420
Total equity
297,162
250,520

As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £46,542 (2017 - £45,143 profit).

The financial statements were approved by the board of directors and authorised for issue on 17 December 2018 and are signed on its behalf by:
17 December 2018
Mr B J Jenkins
Director
Company Registration No. 06873327
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2018
- 11 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2016
2
1,519,161
417,960
1,937,123
Year ended 31 March 2017:
Profit and total comprehensive income for the year
-
-
46,585
46,585
Issue of share capital
21
98
-
-
98
Transfers of excess depreciation on revalued fixed assets
-
(33,087)
33,087
-
Balance at 31 March 2017
100
1,486,074
497,632
1,983,806
Year ended 31 March 2018:
Loss and total comprehensive income for the year
-
-
(136,988)
(136,988)
Issue of share capital
21
100
-
-
100
Transfers of excess depreciation on revalued fixed assets
-
(33,087)
33,087
-
Balance at 31 March 2018
200
1,452,987
393,731
1,846,918
JENKINS HEALTH CARE LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2018
- 12 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2016
100
205,277
205,377
Year ended 31 March 2017:
Profit and total comprehensive income for the year
-
45,143
45,143
Balance at 31 March 2017
100
250,420
250,520
Year ended 31 March 2018:
Profit and total comprehensive income for the year
-
46,542
46,542
Issue of share capital
21
100
-
100
Balance at 31 March 2018
200
296,962
297,162
JENKINS HEALTH CARE LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 MARCH 2018
- 13 -
2018
2017
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
24
261,510
255,587
Interest paid
(79,348)
(80,338)
Income taxes paid
(96,187)
(83,655)
Net cash inflow from operating activities
85,975
91,594
Investing activities
Purchase of tangible fixed assets
(2,201)
-
Proceeds on disposal of tangible fixed assets
-
547,475
Proceeds from other investments and loans
(32,660)
(161,015)
Interest received
4,937
6,108
Net cash (used in)/generated from investing activities
(29,924)
392,568
Financing activities
Proceeds from issue of shares
100
98
Repayment of bank loans
(149,203)
(363,282)
Net cash used in financing activities
(149,103)
(363,184)
Net (decrease)/increase in cash and cash equivalents
(93,052)
120,978
Cash and cash equivalents at beginning of year
140,918
19,940
Cash and cash equivalents at end of year
47,866
140,918
Relating to:
Cash at bank and in hand
79,144
143,461
Bank overdrafts included in creditors payable within one year
(31,278)
(2,543)
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2018
- 14 -
1
Accounting policies
Company information

Jenkins Health Care Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Hollins Care Centre, The Hollins, Cimla, NEATH, UK, SA11 3BQ.

 

The group consists of Jenkins Health Care Limited and all of its subsidiaries.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

  • Section 4 ‘Statement of Financial Position’ – Reconciliation of the opening and closing number of shares;

  • Section 7 ‘Statement of Cash Flows’ – Presentation of a statement of cash flow and related notes and disclosures;

  • Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’ – Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

  • Section 33 ‘Related Party Disclosures’.

The consolidated financial statements incorporate those of Jenkins Health Care Limited and all of its subsidiaries (ie entities that the group controls through its power to govern the financial and operating policies so as to obtain economic benefits). Subsidiaries acquired during the year are consolidated using the merger method.

 

All financial statements are made up to 31 March 2018. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

 

 

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies (Continued)
- 15 -
1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover represents amounts receivable for care and nursing services provided during the year.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% straight line
Fixtures, fittings and equipment
15% reducing balance
Motor vehicles
25% reducing balance
1.5
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Stocks

Stocks are stated at the lower of cost and net realisable value after making due provision for any slow moving or obsolete items.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
1
Accounting policies (Continued)
- 16 -
1.7
Cash at bank and in hand

Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.10
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 17 -
2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Turnover and other revenue
2018
2017
£
£
Other significant revenue
Interest income
4,937
6,108
4
Operating (loss)/profit
2018
2017
£
£
Operating (loss)/profit for the year is stated after charging:
Depreciation of owned tangible fixed assets
108,603
109,256
(Profit)/loss on disposal of tangible fixed assets
-
42,493
Amortisation of intangible assets
125,607
125,607
Cost of stocks recognised as an expense
258,437
186,643
Operating lease charges
4,472
3,828
5
Auditor's remuneration
2018
2017
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
1,000
-
Audit of the financial statements of the company's subsidiaries
4,000
-
5,000
-
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 18 -
6
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2018
2017
2018
2017
Number
Number
Number
Number
Total employees
127
136
-
-

Their aggregate remuneration comprised:

Group
Company
2018
2017
2018
2017
£
£
£
£
Wages and salaries
2,294,094
2,312,815
-
-
Pension costs
7,247
-
-
-
2,301,341
2,312,815
-
-
7
Interest receivable and similar income
2018
2017
£
£
Interest income
Other interest income
4,937
6,108
8
Interest payable and similar expenses
2018
2017
£
£
Interest on bank overdrafts and loans
79,348
80,295
Other interest
-
43
Total finance costs
79,348
80,338
9
Taxation
2018
2017
£
£
Current tax
UK corporation tax on profits for the current period
45,441
85,813
Adjustments in respect of prior periods
(1,490)
(13,176)
Total current tax
43,951
72,637
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
9
Taxation (Continued)
- 19 -

The actual charge for the year can be reconciled to the expected charge based on the profit or loss and the standard rate of tax as follows:

2018
2017
£
£
(Loss)/profit before taxation
(93,037)
119,222
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 19.00% (2017: 20.00%)
(17,677)
23,844
Tax effect of expenses that are not deductible in determining taxable profit
870
1,184
Unutilised tax losses carried forward
30,668
10,863
Depreciation add back
33,155
31,590
Capital allowances
(3,065)
(3,342)
Loss on disposal of fixed assets
-
8,498
Taxation charge for the year
43,951
72,637
10
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 April 2017 and 31 March 2018
1,356,070
Amortisation and impairment
At 1 April 2017
1,042,053
Amortisation charged for the year
125,607
At 31 March 2018
1,167,660
Carrying amount
At 31 March 2018
188,410
At 31 March 2017
314,017
The company had no intangible fixed assets at 31 March 2018 or 31 March 2017.
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 20 -
11
Tangible fixed assets
Group
Freehold land and buildings
Fixtures, fittings and equipment
Motor vehicles
Total
£
£
£
£
Cost or valuation
At 1 April 2017
4,650,000
956,863
19,949
5,626,812
Additions
-
2,201
-
2,201
At 31 March 2018
4,650,000
959,064
19,949
5,629,013
Depreciation and impairment
At 1 April 2017
119,894
895,423
19,948
1,035,265
Depreciation charged in the year
93,428
15,175
-
108,603
At 31 March 2018
213,322
910,598
19,948
1,143,868
Carrying amount
At 31 March 2018
4,436,678
48,466
1
4,485,145
At 31 March 2017
4,530,106
61,440
1
4,591,547
The company had no tangible fixed assets at 31 March 2018 or 31 March 2017.

The freehold and leasehold land and buildings were valued on an open market basis by Christie & Co in 2015, a firm of independent Chartered Surveyors. The directors have considered the carrying value and do not consider it to be materially different to recent valuations undertaken post year end.

If revalued assets were stated on an historical cost basis rather than a fair value basis, the total amounts included would have been as follows:

Group
Company
2018
2017
2018
2017
£
£
£
£
Cost
2,990,344
2,990,344
-
-
Accumulated depreciation
(338,120)
(278,313)
-
-
Carrying value
2,652,224
2,712,031
-
-

 

12
Fixed asset investments
Group
Company
2018
2017
2018
2017
Notes
£
£
£
£
Investments in associates
-
-
1,788,854
1,788,754

 

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
12
Fixed asset investments (Continued)
- 21 -
Movements in fixed asset investments
Company
Shares in group undertakings and participating interests
£
Cost or valuation
At 1 April 2017
1,788,754
Additions
100
At 31 March 2018
1,788,854
Carrying amount
At 31 March 2018
1,788,854
At 31 March 2017
1,788,754

The addition of £100 during the year represents the Group acquisition of 100% of the issued share capital of Cherish Care Homes (Wales) Limited, a company previously under common ultimate control, as part of a share for share exchange.

13
Subsidiaries

Details of the company's subsidiaries at 31 March 2018 are as follows:

Name of undertaking
Registered
Nature of business
Class of
% Held
office
shares held
Direct
Indirect
Cherish Care Homes (Wales) Limited
1
Residential care activities for the elderly and disabled.
Ordinary
100.00
Saint Camillus Limited
1
Residential care activities for the elderly and disabled
Ordinary
100.00
Cefn Lodge Limited
1
Residential care activities for the elderly and disabled.
Ordinary
100.00

1. Hollins Care Centre, The Hollins, Cimla, Neath, UK. SA11 3BQ.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 22 -
14
Financial instruments
Group
Company
2018
2017
2018
2017
£
£
£
£
Carrying amount of financial assets
Debt instruments measured at amortised cost
448,485
447,048
n/a
n/a
Carrying amount of financial liabilities
Measured at amortised cost
2,902,014
3,041,294
n/a
n/a

As permitted by the reduced disclosure framework within FRS 102, the company has taken advantage of the exemption from disclosing the carrying amount of certain classes of financial instruments, denoted by 'n/a' above.

15
Stocks
Group
Company
2018
2017
2018
2017
£
£
£
£
Medication, food and consumables
8,500
9,777
-
-
16
Debtors
Group
Company
2018
2017
2018
2017
Amounts falling due within one year:
£
£
£
£
Trade debtors
71,467
109,290
-
-
Amounts owed by group undertakings
-
-
55,869
33,000
Other debtors
377,018
337,758
-
-
448,485
447,048
55,869
33,000
17
Creditors: amounts falling due within one year
Group
Company
2018
2017
2018
2017
Notes
£
£
£
£
Bank loans and overdrafts
19
248,192
199,716
47,665
46,258
Trade creditors
44,154
62,776
439
2,640
Amounts due to undertakings in which the group has a participating interest
57,812
141,677
-
-
Corporation tax payable
52,852
105,088
-
-
Other taxation and social security
69,400
37,162
-
-
Other creditors
241,094
160,158
537,704
518,650
Accruals and deferred income
24,799
22,060
-
100
738,303
728,637
585,808
567,648
JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 23 -
18
Creditors: amounts falling due after more than one year
Group
Company
2018
2017
2018
2017
Notes
£
£
£
£
Bank loans and overdrafts
19
2,285,963
2,454,907
973,084
1,020,749
Amounts included above which fall due after five years are as follows:
Payable by instalments
1,403,359
1,651,708
767,476
821,211
19
Loans and overdrafts
Group
Company
2018
2017
2018
2017
£
£
£
£
Bank loans
2,502,877
2,652,080
1,020,749
1,067,007
Bank overdrafts
31,278
2,543
-
-
2,534,155
2,654,623
1,020,749
1,067,007
Payable within one year
248,192
199,716
47,665
46,258
Payable after one year
2,285,963
2,454,907
973,084
1,020,749
Amounts included above which fall due after five years:
Payable by instalments
1,403,359
1,651,708
767,476
821,211

The long-term loans are secured by fixed and floating charges over all property and assets of the Group.

Interest is charged on bank loans at variable rates and are repayable in more than 5 years by regular monthly repayments.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 24 -
20
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
2018
2017
Group
£
£
Accelerated capital allowances
6,500
6,500
Revaluations
332,000
332,000
338,500
338,500
The company has no deferred tax assets or liabilities.
There were no deferred tax movements in the year.

 

21
Share capital
Group and company
2018
2017
Ordinary share capital
£
£
Issued and fully paid
152 Ordinary A of £1 each
152
100
24 Ordinary B of £1 each
24
-
12 Ordinary C of £1 each
12
-
12 Ordinary D of £1 each
12
-
200
100

100 Ordinary £1 shares were issued during the year as part of a share for share exchange whereby the company acquired 100% of the issued share capital of Cherish Care Homes (Wales) Limited, a company under common ultimate control.

 

200 Ordinary £1 shares were then designated during the year as 152 Ordinary A £1 shares, 24 Ordinary B £1 shares, 12 Ordinary C £1 shares and 12 Ordinary D £1 shares.

22
Related party transactions
Transactions with related parties

During the year the group entered into the following transactions with related parties:

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
22
Related party transactions (Continued)
- 25 -
Management fees receivable
2018
2017
£
£
Group
Entities over which the entity has control, joint control or significant influence
10,678
40,000

The following amounts were outstanding at the reporting end date:

Amounts owed to related parties
2018
2017
£
£
Group
Entities over which the group has control, joint control or significant influence
57,812
141,677
Company
Entities over which the company has control, joint control or significant influence
116,599
117,044

The following amounts were outstanding at the reporting end date:

Amounts owed by related parties
2018
2017
Balance
Balance
£
£
Group
Directors
335,750
302,330

The Group charged interest on outstanding directors loans during the period of £4,937 (2017: £6,108)

23
Controlling party

The company is controlled by the director Mrs M Jenkins who owns the majority of share capital.

JENKINS HEALTH CARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2018
- 26 -
24
Cash generated from group operations
2018
2017
£
£
(Loss)/profit for the year after tax
(136,988)
46,585
Adjustments for:
Taxation charged
43,951
72,637
Finance costs
79,348
80,338
Investment income
(4,937)
(6,108)
(Gain)/loss on disposal of tangible fixed assets
-
42,493
Amortisation and impairment of intangible assets
125,607
125,607
Depreciation and impairment of tangible fixed assets
108,603
109,256
Movements in working capital:
Decrease/(increase) in stocks
1,277
(6)
Decrease in debtors
31,223
487,412
Increase/(decrease) in creditors
13,426
(702,627)
Cash generated from operations
261,510
255,587
2018-03-312017-04-01falseCCH SoftwareCCH Accounts Production 2018.300Mr B J JenkinsMrs M E JenkinsMr T S Jenkins068733272017-04-012018-03-3106873327bus:Director12017-04-012018-03-3106873327bus:Director22017-04-012018-03-3106873327bus:Director32017-04-012018-03-3106873327bus:RegisteredOffice2017-04-012018-03-3106873327bus:Consolidated2018-03-3106873327bus:Consolidated2017-04-012018-03-31068733272018-03-31068733272017-03-3106873327core:CurrentFinancialInstruments2018-03-3106873327core:CurrentFinancialInstruments2017-03-3106873327core:Non-currentFinancialInstruments2018-03-3106873327core:Non-currentFinancialInstruments2017-03-3106873327core:ShareCapital2018-03-3106873327core:ShareCapital2017-03-31068733272016-04-012017-03-3106873327core:ShareCapital2017-04-012018-03-3106873327core:LandBuildingscore:OwnedOrFreeholdAssets2017-04-012018-03-3106873327core:FurnitureFittings2017-04-012018-03-3106873327core:MotorVehicles2017-04-012018-03-3106873327core:Subsidiary12017-04-012018-03-3106873327core:Subsidiary22017-04-012018-03-3106873327core:Subsidiary32017-04-012018-03-3106873327core:Subsidiary112017-04-012018-03-3106873327core:Subsidiary212017-04-012018-03-3106873327core:Subsidiary312017-04-012018-03-3106873327core:Subsidiary122017-04-012018-03-3106873327core:Subsidiary222017-04-012018-03-3106873327core:Subsidiary322017-04-012018-03-3106873327bus:PrivateLimitedCompanyLtd2017-04-012018-03-3106873327bus:FRS1022017-04-012018-03-3106873327bus:Audited2017-04-012018-03-3106873327bus:ConsolidatedGroupCompanyAccounts2017-04-012018-03-3106873327bus:FullAccounts2017-04-012018-03-31xbrli:purexbrli:sharesiso4217:GBP